Company profile
Chamishi Therapeutics company profile
Chamishi Therapeutics, a drug discovery and development company focused on neurodegenerative diseases and other related disorders. Chamishi will initially focus on developing antisense oligonucleotide (ASO) therapies for Glucosylceramidase Beta Acid (GBA)-Parkinson’s disease.
Business identity
- Phone number
- 630-336-3541
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00051-00100 employees
- Founded
- 2019-01-01
Headquarters
- Headquarters
- Beckley, West Virginia, United States
- Postal code
- 60015
- Country code
- US
- Continent
- North America